Key Developments: Merit Medical Systems Inc (MMSI.O)

MMSI.O on Nasdaq

21.35USD
12:47pm EDT
Change (% chg)

$-0.19 (-0.88%)
Prev Close
$21.54
Open
$21.70
Day's High
$21.78
Day's Low
$21.26
Volume
131,913
Avg. Vol
305,771
52-wk High
$22.15
52-wk Low
$11.41

Search Stocks

Latest Key Developments (Source: Significant Developments)

Merit Medical Systems Inc gives FY 2015 mixed outlook
Tuesday, 24 Feb 2015 04:00pm EST 

Merit Medical Systems Inc:Expects FY 2015 revenues to be in the range of $535-$545 mln.Expects FY 2015 GAAP earnings per share to be in the range of $0.63-$0.67.Expects FY 2015 non-GAAP earnings per share to be in the range of $0.85-$0.89.FY 2015 revenue of $551 mln, EPS of $0.81 - Thomson Reuters I/B/E/S.  Full Article

Merit Medical and Bard Access Systems Inc settle dispute
Thursday, 30 Oct 2014 09:30am EDT 

Merit Medical Systems Inc:Announced that Merit and Bard Access Systems have settled a dispute regarding the distribution of the SecureLoc Safety Introducer Needle.Under the terms of a settlement agreement, Bard Access Systems granted Merit a non-exclusive, worldwide license to manufacture and distribute the SecureLoc Safety Introducer Needle under its own trademark, and;.Covenant not to sue Merit for the term of all patents covering the SecureLoc.Both parties agreed to dismiss all claims with prejudice in the litigation pending in the Third District Court in Utah.  Full Article

Merit Medical Systems Inc raises FY 2014 revenue outlook, lowers EPS outlook
Tuesday, 29 Jul 2014 04:00pm EDT 

Merit Medical Systems Inc:Now expects FY 2014 revenues will be in the range of $511-$515 million, an increase of about 14-15 pct, compared to revenues of $449.0 million for FY 2013.FY 2014 GAAP earnings per share will be in the range of $0.39-$0.43, compared to GAAP earnings per share of $0.39 for FY 2013.FY 2014 non-GAAP earnings per share will be in the range of $0.61-$0.65, compared to non-GAAP earnings per share of $0.71 for FY 2013.FY 2014 revenue of $494 million and EPS of $0.76 - Thomson Reuters I/B/E/S.  Full Article

Merit Medical Systems Inc receives regulatory approval for tracheobronchial stent systems in China
Wednesday, 9 Jul 2014 09:30am EDT 

Merit Medical Systems Inc:Announces that it has received approval from the Chinese Food and Drug Administration (CFDA) to market Merit's Aero Tracheobronchial Stent System.Approval is for a period of five years and includes the over-the-wire (OTW) system as well as the direct visualization (DV) system.Approval covers 33 catalog items.  Full Article

Merit Medical Systems Inc gives FY 2014 guidance in line with analysts' estimates
Monday, 3 Mar 2014 04:00pm EST 

Merit Medical Systems Inc:Expects FY 2014 sales of $488.0 to $498.0 million.Expects FY 2014 earnings on a non-GAAP basis of $0.74 to $0.78 per share.Expects FY 2014 on GAAP basis of $0.53 to $0.57 per share.FY 2014 revenue of $489 million and EPS of $0.76 - Thomson Reuters I/B/E/S.  Full Article

Search Stocks